The request from Industry for extension of deadlines for submission of Nitrosamine Risk Assessments has been rejected by FDA
https://www.gmp-compliance.org/gmp-news/nitrosamine-impurities-fda-rejects-the-extension-of-deadline-for-submission-of-risk-assessments?utm_source=Newsletter&utm_medium=email&utm_campaign=ECA+GMP+Newsletter+-+2021+-+KW32+-+PEU